Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias

Human Pathology

Volumn 41, Issue 6, 2010, Pages 902-909

  Lisovsky, Mikhail ^a   Dresser, Karen ^b   Woda, Bruce ^b   Mino Kenudson, Mari ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Ductal adenocarcinoma of the pancreas; Lgl2; Pancreatic intraepithelial neoplasia; PanIN

Indexed keywords

CELL PROTEIN; LETHAL GIANT LARVAE 2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CELL POLARITY; CYTOSKELETAL PROTEINS; DIAGNOSIS, DIFFERENTIAL; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; PANCREAS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951937872     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.12.004     Document Type: Article

References (34)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221 (1995) 721-731 discussion 731-723
3. Sipos B., Frank S., Gress T., Hahn S., and Kloppel G. Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology 9 (2009) 45-54
4. Brentnall T.A. Management strategies for patients with hereditary pancreatic cancer. Curr Treat Options Oncol 6 (2005) 437-445
5. Lowenfels A.B., Maisonneuve P., Cavallini G., et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328 (1993) 1433-1437
6. Malka D., Hammel P., Maire F., et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51 (2002) 849-852
7. Hruban R.H., Takaori K., Klimstra D.S., et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28 (2004) 977-998
8. Maitra A., Adsay N.V., Argani P., et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16 (2003) 902-912
9. Hruban R.H., Pitman M.B., and Klimstra D.S. Ductal adenocarcinoma of the pancreas. In: Hruban R.H., et al. (Ed). Atlas of tumor pathology-pancreas (2008), ARP Press, Baltimore
10. Longnecker D.S., Adsay N.V., Fernandez-del Castillo C., et al. Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement. Pancreas 31 (2005) 344-349
11. Gateff E. Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 200 (1978) 1448-1459
12. Albertson R., and Doe C.Q. Dlg, Scrib and Lgl regulate neuroblast cell size and mitotic spindle asymmetry. Nat Cell Biol 5 (2003) 166-170
13. Betschinger J., and Knoblich J.A. Dare to be different: asymmetric cell division in Drosophila, C. elegans and vertebrates. Curr Biol 14 (2004) R674-685
14. Bilder D. Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev 18 (2004) 1909-1925
15. Grifoni D., Garoia F., Schimanski C.C., et al. The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo. Oncogene 23 (2004) 8688-8694
16. Schimanski C.C., Schmitz G., Kashyap A., et al. Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 24 (2005) 3100-3109
17. Lisovsky M., Dresser K., Baker S., et al. Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: an immunohistochemical study. Mod Pathol 22 (2009) 977-984
18. Kim G.E., Bae H.I., Park H.U., et al. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 123 (2002) 1052-1060
19. Prasad N.B., Biankin A.V., Fukushima N., et al. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 65 (2005) 1619-1626
20. Wilentz R.E., Iacobuzio-Donahue C.A., Argani P., et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60 (2000) 2002-2006
21. Yamano M., Fujii H., Takagaki T., Kadowaki N., Watanabe H., and Shirai T. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 156 (2000) 2123-2133
22. Luttges J., Galehdari H., Brocker V., et al. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158 (2001) 1677-1683
23. Andea A., Sarkar F., and Adsay V.N. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 16 (2003) 996-1006
24. Buchholz M., Braun M., Heidenblut A., et al. Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24 (2005) 6626-6636
25. Kozuka S., Sassa R., Taki T., et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 43 (1979) 1418-1428
26. Hisa T., Suda K., Nobukawa B., et al. Distribution of intraductal lesions in small invasive ductal carcinoma of the pancreas. Pancreatology 7 (2007) 341-346
27. Brat D.J., Lillemoe K.D., Yeo C.J., Warfield P.B., and Hruban R.H. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 22 (1998) 163-169
28. Lin F., Shi J., Liu H., et al. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis. Am J Surg Pathol 32 (2008) 78-91
29. Yantiss R.K., Woda B.A., Fanger G.R., et al. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 29 (2005) 188-195
30. Plant P.J., Fawcett J.P., Lin D.C., et al. A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat Cell Biol 5 (2003) 301-308
31. Yamanaka T., Horikoshi Y., Sugiyama Y., et al. Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity. Curr Biol 13 (2003) 734-743
32. Habbe N., Shi G., Meguid R.A., et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A 105 (2008) 18913-18918
33. De La O.J., Emerson L.L., Goodman J.L., et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 105 (2008) 18907-18912
34. Adsay V., Logani S., Sarkar F., Crissman J., and Vaitkevicius V. Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant. Am J Surg Pathol 24 (2000) 493-504